Okupe Oluyemi's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed May 22, 2024
- Accession no.
- 0001773751-24-000152
- Filed
- May 22, 2024
- Trade date
- May 20-21, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $819.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Okupe OluyemiCIK 0001907056 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2024 | Class A Common Stock | SSaleDisposed | −6,900 | $20.01F2 | −$138,069 | 161,727 | Direct | |
| May 21, 2024 | Class A Common Stock | MOption exerciseAcquired | +28,084 | $5.01 | +$140,700.84 | 189,811 | Direct | |
| May 21, 2024 | Class A Common Stock | SSaleDisposed | −31,433 | $17.86F4 | −$561,393.38 | 158,378 | Direct | |
| May 21, 2024 | Class A Common Stock | SSaleDisposed | −3,349 | $17.97F5 | −$60,181.53 | 155,029 | Direct | |
| May 21, 2024 | Class A Common Stock | SSaleDisposed | −3,349 | $17.95F6 | −$60,114.55 | 151,680 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2024 | Class A Common Stock | MOption exerciseDisposed | −28,084 | $0.00 | $0 | 936,311 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.04. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.63 - $18.15. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.88 - $18.095. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.86 - $18.07. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.